Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00032260.xml
Download PDF
Digestive Disease Interventions 2017; 01(03): 195-200
DOI: 10.1055/s-0037-1608807
DOI: 10.1055/s-0037-1608807
Review Article
Liver Metastasis: Update on Thermal and Nonthermal Ablative Therapies
Further Information
Publication History
11 July 2017
26 October 2017
Publication Date:
17 November 2017 (online)
Abstract
The liver is one of the most common sites of metastatic disease from several primary malignancies. While most treatment regimens incorporate a combination of chemotherapy and surgical treatments, ablative techniques are increasingly being used for the treatment of recurrent disease. This article will provide an update on the current status of thermal and nonthermal therapies to treat metastatic liver disease.
-
References
- 1 Metastatic Liver Cancer - Hepatic and Biliary Disorders. Merck Manuals Professional Edition. http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/liver-masses-and-granulomas/metastatic-liver-cancer . Accessed January 7, 2017
- 2 Bisceglie AMD, Befeler AS. Hepatic tumors and cysts. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 10th ed. Philadelphia, PA: Elsevier/Saunders; 2016: 1603-1627.e8 https://www-clinicalkey-com.ezp-prod1.hul.harvard.edu/#!/content/book/3-s2.0-B978145574692700096X?scrollTo=%23s0400 . Accessed January 7, 2017
- 3 Iacobuzio-Donahue. Christine F Linda. Secondary tumours of the liver and intrahepatic bile ducts. http://www.pubcan.org/page.php?pageid=10 . Accessed January 7, 2017
- 4 Disibio G, French SW. Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med 2008; 132 (06) 931-939
- 5 Neumann UP, Seehofer D, Neuhaus P. The surgical treatment of hepatic metastases in colorectal carcinoma. Dtsch Arztebl Int 2010; 107 (19) 335-342 . Doi: 10.3238/arztebl.2010.0335
- 6 Improvement in Survival for Patients with Liver Metastases. Memorial Sloan Kettering Cancer Center. https://www.mskcc.org/clinical-updates/improvement-survival-patients-liver-metastases . Accessed January 7, 2017.
- 7 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66 (01) 7-30 . Doi: 10.3322/caac.21332
- 8 Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA 2015; 313 (02) 165-173 . Doi: 10.1001/jama.2014.17322
- 9 Hoe AL, Royle GT, Taylor I. Breast liver metastases--incidence, diagnosis and outcome. J R Soc Med 1991; 84 (12) 714-716
- 10 Zinser JW, Hortobagyi GN, Buzdar AU, Smith TL, Fraschini G. Clinical course of breast cancer patients with liver metastases. J Clin Oncol 1987; 5 (05) 773-782 . Doi: 10.1200/JCO.1987.5.5.773
- 11 Selzner M, Morse MA, Vredenburgh JJ, Meyers WC, Clavien P-A. Liver metastases from breast cancer: long-term survival after curative resection. Surgery 2000; 127 (04) 383-389 . Doi: 10.1067/msy.2000.103883
- 12 Wyld L, Gutteridge E, Pinder SE. , et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 2003; 89 (02) 284-290 . Doi: 10.1038/sj.bjc.6601038
- 13 Covey AM, Sofocleous CT. Radiofrequency ablation as a treatment strategy for liver metastases from breast cancer. Semin Intervent Radiol 2008; 25 (04) 406-412 . Doi: 10.1055/s-0028-1102996
- 14 Chua TC, Saxena A, Liauw W, Chu F, Morris DL. Hepatic resection for metastatic breast cancer: a systematic review. Eur J Cancer 2011; 47 (15) 2282-2290 . Doi: 10.1016/j.ejca.2011.06.024
- 15 Margonis GA, Buettner S, Sasaki K. , et al. The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis. HPB 2016; 18 (08) 700-705 . Doi: 10.1016/j.hpb.2016.05.014
- 16 Sadot E, Lee SY, Sofocleous CT. , et al. Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients. Ann Surg 2016; 264 (01) 147-154 . Doi: 10.1097/SLA.0000000000001371
- 17 The role of local therapies in metastatic breast cancer - UpToDate. https://www.uptodate.com/contents/the-role-of-local-therapies-in-metastatic-breast-cancer?source=search_result&search=breast%20cancer%20local&selectedTitle=4~150#H14 . Accessed January 12, 2017
- 18 Seidensticker M, Garlipp B, Scholz S. , et al. Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study). BMC Cancer 2015; 15: 517 . Doi: 10.1186/s12885-015-1499-z
- 19 Veltri A, Gazzera C, Barrera M. , et al. Radiofrequency thermal ablation (RFA) of hepatic metastases (METS) from breast cancer (BC): an adjunctive tool in the multimodal treatment of advanced disease. Radiol Med (Torino) 2014; 119 (05) 327-333 . Doi: 10.1007/s11547-013-0354-z
- 20 Niu L, Mu F, Zhang C. , et al. Cryotherapy protocols for metastatic breast cancer after failure of radical surgery. Cryobiology 2013; 67 (01) 17-22 . Doi: 10.1016/j.cryobiol.2013.04.004
- 21 Bala MM, Riemsma RP, Wolff R, Kleijnen J. Cryotherapy for liver metastases. Cochrane Database Syst Rev 2013; (06) CD009058 . Doi: 10.1002/14651858.CD009058.pub2
- 22 Zhang W, Yu H, Guo Z. , et al. Percutaneous cryoablation of liver metastases from breast cancer: initial experience in 17 patients. Clin Radiol 2014; 69 (03) 231-238 . Doi: 10.1016/j.crad.2013.09.014
- 23 Colorectal Cancer Initial Diagnosis: Screening Colonoscopy, Diagnostic Colonoscopy, or Emergent Surgery, and Tumor Stage and Size at Initial Presentation - ClinicalKey. https://www-clinicalkey-com.ezp-prod1.hul.harvard.edu/#!/content/playContent/1-s2.0-S153300281500095X?returnurl=null&referrer=null . Accessed January 7, 2017
- 24 Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep 2016; 6: 29765 . Doi: 10.1038/srep29765
- 25 Adam R, Delvart V, Pascal G. , et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240 (04) 644-657 , discussion 657–658. Doi: 10.1097/01.sla.0000141198.92114.f6
- 26 Goéré D, Deshaies I, de Baere T. , et al. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Ann Surg 2010; 251 (04) 686-691 . Doi: 10.1097/SLA.0b013e3181d35983
- 27 Cirocchi R, Trastulli S, Boselli C. , et al. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev 2012; (06) CD06317 . doi:10.1002/14651858
- 28 Ruers T, Punt C, Van Coevorden F. , et al; EORTC Gastro-Intestinal Tract Cancer Group, Arbeitsgruppe Lebermetastasen und—tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO) and the National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG). Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol 2012; 23 (10) 2619-2626 . Doi: 10.1093/annonc/mds053
- 29 Ruers T, Punt CJA, van Coevorden F. , et al. Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomized phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC). J Clin Oncol 2015; 33: 3501
- 30 Nonsurgical local treatment strategies for colorectal cancer liver metastases - UpToDate. https://www.uptodate.com/contents/nonsurgical-local-treatment-strategies-for-colorectal-cancer-liver-metastases?source=search_result&search=nonsurgical%20local%20treatment%20strategies%20for%20colorectal&selectedTitle=1~150 . Accessed January 23, 2017
- 31 Sartori S, Tombesi P, Di Vece F. Thermal ablation in colorectal liver metastases: lack of evidence or lack of capability to prove the evidence?. World J Gastroenterol 2016; 22 (13) 3511-3515 . Doi: 10.3748/wjg.v22.i13.3511
- 32 Ruers T, Van Coevorden F, Punt CJ. , et al; European Organisation for Research and Treatment of Cancer (EORTC); Gastro-Intestinal Tract Cancer Group; Arbeitsgruppe Lebermetastasen und tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG). Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. J Natl Cancer Inst 2017; 109 (09)
- 33 Ruers TJM, Joosten JJ, Wiering B. , et al. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol 2007; 14 (03) 1161-1169 . Doi: 10.1245/s10434-006-9312-5
- 34 Lee W-S, Yun SH, Chun H-K. , et al. Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol 2008; 42 (08) 945-949 . Doi: 10.1097/MCG.0b013e318064e752
- 35 White RR, Avital I, Sofocleous CT. , et al. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg 2007; 11 (03) 256-263 . Doi: 10.1007/s11605-007-0100-8
- 36 Stang A, Fischbach R, Teichmann W, Bokemeyer C, Braumann D. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 2009; 45 (10) 1748-1756 . Doi: 10.1016/j.ejca.2009.03.012
- 37 Van Tilborg AA, Meijerink MR, Sietses C. , et al. Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. Br J Radiol 2011; 84 (1002): 556-565 . Doi: 10.1259/bjr/78268814
- 38 Gleisner AL, Choti MA, Assumpcao L, Nathan H, Schulick RD, Pawlik TM. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. Arch Surg 2008; 143 (12) 1204-1212
- 39 Otto G, Düber C, Hoppe-Lotichius M, König J, Heise M, Pitton MB. Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery. Ann Surg 2010; 251 (05) 796-803 . Doi: 10.1097/SLA.0b013e3181bc9fae
- 40 Ko S, Jo H, Yun S, Park E, Kim S, Seo H-I. Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases. World J Gastroenterol 2014; 20 (02) 525-531 . Doi: 10.3748/wjg.v20.i2.525
- 41 Shady W, Petre EN, Gonen M. , et al. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes–A 10-year Experience at a Single Center. Radiology 2016; 278 (02) 601-611 . Doi: 10.1148/radiol.2015142489
- 42 Lee H, Heo JS, Cho YB. , et al. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis. World J Gastroenterol 2015; 21 (11) 3300-3307 . Doi: 10.3748/wjg.v21.i11.3300
- 43 Kim KH, Yoon YS, Yu CS. , et al. Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc 2011; 81 (01) 25-34 . Doi: 10.4174/jkss.2011.81.1.25
- 44 Lu DSK, Raman SS, Limanond P. , et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14 (10) 1267-1274
- 45 Bala MM, Riemsma RP, Wolff R, Kleijnen J. Microwave coagulation for liver metastases. Cochrane Database Syst Rev 2013; (10) CD010163 . Doi: 10.1002/14651858.CD010163.pub2
- 46 Eng OS, Tsang AT, Moore D. , et al. Outcomes of microwave ablation for colorectal cancer liver metastases: a single center experience. J Surg Oncol 2015; 111 (04) 410-413 . Doi: 10.1002/jso.23849
- 47 Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 2000; 89 (02) 276-284
- 48 van Tilborg AAJM, Scheffer HJ, de Jong MC. , et al. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts. Cardiovasc Intervent Radiol 2016; 39 (10) 1438-1446 . Doi: 10.1007/s00270-016-1413-3
- 49 Deipolyi AR, Golberg A, Yarmush ML, Arellano RS, Oklu R. Irreversible electroporation: evolution of a laboratory technique in interventional oncology. Diagn Interv Radiol 2014; 20 (02) 147-154
- 50 Scheffer HJ, Melenhorst MC, Echenique AM. , et al. Irreversible Electroporation for Colorectal Liver Metastases. Tech Vasc Interv Radiol 2015; 18 (03) 159-169
- 51 Niessen C, Beyer LP, Pregler B. , et al. Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients. J Vasc Interv Radiol 2016; 27 (04) 480-486
- 52 Scheffer HJ, Nielsen K, van Tilborg AA. , et al. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study. Eur Radiol 2014; 24 (10) 2467-2475
- 53 Frühling P, Nilsson A, Duraj F, Haglund U, Norén A. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: short to mid-term results. Eur J Surg Oncol 2017; 43 (04) 751-757
- 54 Siperstein AE, Berber E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Surg 2001; 25 (06) 693-696
- 55 Oberg K. The use of chemotherapy in the management of neuroendocrine tumors. Endocrinol Metab Clin North Am 1993; 22 (04) 941-952
- 56 Mohan H, Nicholson P, Winter DC. , et al. Radiofrequency ablation for neuroendocrine liver metastases: a systematic review. J Vasc Interv Radiol 2015; 26 (07) 935-942.e1
- 57 Berber E, Siperstein A. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol 2008; 15 (10) 2757-2764
- 58 van der Burg ME, van Lent M, Buyse M. , et al; Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. N Engl J Med 1995; 332 (10) 629-634
- 59 Akladios C, Baldauf JJ, Marchal F. , et al. Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer?. Oncology 2016; 91 (06) 331-340
- 60 Gervais DA, Arellano RS, Mueller PR. Percutaneous radiofrequency ablation of ovarian cancer metastasis to the liver: indications, outcomes, and role in patient management. AJR Am J Roentgenol 2006; 187 (03) 746-750